ArticleAmerican journal of health economics2025
Medicare Advantage Has Lower Resource Use and Better Quality of Care than Traditional Medicare.
Article in American journal of health economics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Quality, Cost, and Timeliness of Cancer Treatment in Medicare Advantage and Traditional Medicare.JAMA internal medicine · 2026Article
- Potentially Inappropriate Medication Use Following Hospital Discharge Among Medicare Beneficiaries.The American journal of managed care · 2026Observational
- Algorithmic decision-making in health care: Evidence from post-acute care in Medicare Advantage.Journal of health economics · 2025Article
- Resource Use and Care Quality Differences Among Medicare Beneficiaries Undergoing Chemotherapy.JAMA network open · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Medicare Advantage (MA) is a private alternative to publicly administered Traditional Medicare (TM). Whether private MA firms deliver Medicare services more efficiently than public TM coverage has long been an important inquiry. We use newly available national MA encounter data to compare resource use and quality of care between MA and TM. We find that adjusted total resource use is $206-$284 (12.8-17.5%) per beneficiary per month lower in MA than in TM between 2016 and 2019. The estimates vary depending on how we account for differences in coding intensity and patient characteristics between MA and TM. Quality of care, measured by adverse health events and care process indicators, is better in MA than TM. Resource use reduction and quality improvement are larger among higher-risk MA patients. Resource use reduction and quality improvement also differ by MA plan type and star ratings. MA's advantage over TM in reducing resource use decreased modestly between 2016 and 2019, and MA's advantage in improving quality of care decreased for one measure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.